Anbio Biotechnology - Class A Ordinary Shares (NNNN)
21.50
-0.32 (-1.47%)
NASDAQ · Last Trade: Mar 18th, 12:16 AM EDT
Detailed Quote
| Previous Close | 21.82 |
|---|---|
| Open | 22.99 |
| Bid | 21.40 |
| Ask | 22.48 |
| Day's Range | 20.98 - 22.99 |
| 52 Week Range | 5.890 - 55.65 |
| Volume | 25,082 |
| Market Cap | - |
| PE Ratio (TTM) | 383.93 |
| EPS (TTM) | 0.1 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 50,537 |
Chart
News & Press Releases
FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming KeyBanc Capital Markets Virtual Healthcare Forum on Wednesday, March 18, 2026.
By Anbio Biotechnology · Via GlobeNewswire · March 17, 2026
Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks already soaring over 400% post-debut.
Via Benzinga · October 7, 2025
Via Benzinga · October 3, 2025
Via Benzinga · October 3, 2025
Via Benzinga · October 3, 2025
Via Benzinga · October 2, 2025
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.
By Anbio Biotechnology · Via GlobeNewswire · August 8, 2025
Via Benzinga · July 8, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · May 15, 2025
Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration
By Anbio Biotechnology · Via GlobeNewswire · May 15, 2025
Via Benzinga · April 3, 2025

AI Mobility provider Webus International, steel industry veteran Luda Technology, Chinese ad services provider LZ Technology, and Singapore-based med-tech Basel Medical all made their public debuts this week.
Via Talk Markets · March 2, 2025